Collegium Pharmaceutical (COLL) Research & Development (2014 - 2022)
Collegium Pharmaceutical's Research & Development came in at -$3.98 million for Q4 2022, compared with $1.61 million a year earlier.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Research & Development (2014 - 2022) Analysis & Trends
For FY2022, Collegium Pharmaceutical's Research & Development was $3.98 million, down 57.9% from FY2021.
- Research & Development has declined in each of the last three years, with a five-year compound annual growth rate of -14.2% (FY2017 to FY2022).
- Going back by year, Research & Development was $9.45 million in FY2021 (-3.3%), $9.77 million in FY2020 (-5.5%), $10.34 million in FY2019 (+19.4%) and $8.66 million in FY2018 (+1.0%).
- The Q4 2022 figure represents the lowest quarterly Research & Development in data going back to Q1 2014.
- Year-over-year, Research & Development increased in three of the last five quarters, with growth averaging 3.5%.
- The fastest year-over-year change in Research & Development over five years came in Q2 2021 (growth of 38.9%), and the weakest in Q4 2021 (a decline of 34.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Collegium Pharmaceutical | 735.44 Mn | -488.33 Mn | 110.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 3.98 Mn |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Mar 31, 2021 | 2.93 Mn |
| Dec 31, 2020 | 2.47 Mn |
| Sep 30, 2020 | 2.14 Mn |
| Jun 30, 2020 | 2.49 Mn |
| Mar 31, 2020 | 2.67 Mn |
| Dec 31, 2019 | 2.40 Mn |
| Sep 30, 2019 | 2.49 Mn |
| Jun 30, 2019 | 2.46 Mn |
| Mar 31, 2019 | 2.99 Mn |
| Dec 31, 2018 | 2.25 Mn |
| Sep 30, 2018 | 1.91 Mn |
| Jun 30, 2018 | 2.24 Mn |
| Mar 31, 2018 | 2.27 Mn |
| Dec 31, 2017 | 2.19 Mn |
| Sep 30, 2017 | 2.07 Mn |
| Jun 30, 2017 | 2.18 Mn |
API Access
Collegium Pharmaceutical Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=COLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();